VivoSeq
Other

Ketorolac

0

Pipeline Programs↗

6

Active Trials↗

1

Companies Involved↗

Ketorolac is an early-stage landscape with 0 programs across 1 company. The most active players are AbbVie.

Intelligence

Pipeline Metrics

Competitive Density

21/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

73/100

Attrition Rate

20/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

AbbVie logo

AbbVie

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

40

clinical trials

Completed22 · 55%
Terminated5 · 13%
Unknown status4 · 10%
Recruiting4 · 10%
Withdrawn3 · 8%
Enrolling by invitation1 · 3%
Other1 · 3%

Clinical Trials

Trial Activity

40 trials

Triamcinolone Ketorolac (TriKe) Knee Trial
Recruiting·UUnited Health Services Hospitals, Inc.·Phase 4·NCT05336968·150 enrolled
Ketorolac in Palatoplasty
Recruiting·TThe University of Texas Health Science Center, Houston·Phase 4·NCT04771156·74 enrolled
Fentanyl Versus Ketorolac as an Adjuvant to Peribulbar Block for Anterior Segment Surgeries
Recruiting·—·N/A·NCT07141589·168 enrolled
Intra-nasal Ketorolac for Acute Ureteral Stent-associated Pain Following Ureteroscopy for Stone Disease
Recruiting·UUniversity of Texas Southwestern Medical Center·Phase 1/2·NCT06158620·80 enrolled
Comparing Intramuscular Fentanyl and Ketorolac With Nerve of Arnold (NOA) Block for Bilateral Myringotomy
Not yet recruiting·UUniversity of South Alabama·Phase 4·NCT07276906·300 enrolled
Oral Ketorolac for IUD Pain Reduction
Enrolling by invitation·UUniversity of North Carolina, Chapel Hill·Phase 2·NCT06853327·108 enrolled
Paracetamol Compared With Ketorolac for Post-operative Analgetic
Completed·IIndonesia University·Phase 4·NCT05523102·85 enrolled
A Comparison of Peak Aqueous Penetration of Acuvail (Ketorolac 0.45%), Xibrom (Bromfenac 0.09%), and Nevanac (Nepafenac 0.1%)in Patients Undergoing Phacoemulsification
Completed·FFrank A. Bucci, Jr., M.D.·Phase 4·NCT01001806·126 enrolled
Assessment of Nasal Deposition and Clearance of Ketorolac Solution Administered Using the Valois Nasal Spray Device
Completed·EEgalet Ltd·Phase 1·NCT01356212·13 enrolled
Adjuncts to IVRA, a Comparison Between Ketorolac and Paracetamol
Completed·—·Phase 3·NCT03485625·60 enrolled
Open Label Study to Assess the Pharmacokinetics of Intranasal Ketorolac Tromethamine Following Fluticasone Propionate in Healthy Subjects
Completed·EEgalet Ltd·Phase 1·NCT01365611·36 enrolled
Ketamine-ketorolac Versus Fentanyl- Ketorolac I.M in Children During Bone Marrow Biopsy
Completed·MMansoura University·Phase 4·NCT03649334·80 enrolled
Oral Ketorolac for Pain Relief During IUD Insertion
Completed·OOhioHealth·Phase 4·NCT03031795·71 enrolled
Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase
Completed·FFlorida Eye Microsurgical Institute·Phase 4·NCT00520260·42 enrolled
Study to Assess the PK of Ketorolac Tromethamine Intranasal and to Assess the Effects of a Oxymetazoline Hydrochloride on the PK of Ketorolac Tromethamine
Completed·EEgalet Ltd·Phase 1·NCT01363089·21 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)